DOI: https://doi.org/10.21203/rs.2.11922/v3
Intracranial vertebrobasilar dissecting aneurysms (VBDAs) are not uncommon, and may exhibit intimal flaps, double lumens and intramural haematoma (IMH).1 Catheter angiography could provide dynamic images with good spatial resolution, and has long been regarded as the gold standard for the diagnosis of arterial dissection. However, catheter angiography generally provides intensity projection images, not the cross-sectional images, which limits the capability for detecting these characteristic signs of dissection,2,3 and often reveals pearl and string sign, fusiform or serpentine dilation, even perhaps an arterial occlusion.3
High resolution magnetic resonance vessel wall imaging (HRMR VWI) could provide cross-sectional images, and has been increasingly used in intracranial artery diseases.4 Using two dimensional fast spin echo (2D FSE) sequences and black blood technique, the intracranial arterial wall can been visualized with greater sensitivity for the detection of vessel features suggestive or diagnostic of dissection.2,6 However, the identification may be impaired given the inherent curvature of intracranial arteries, limited anatomic coverage, and anisotropic spatial resolution,6,7 leading to false-negative results, especially for cases involving 2 or more vessels.3
An efficient 3D VWI technique, called Sampling Perfection with Application optimized contrasts by using different flip angle Evolutions (SPACE), was introduced in recent years,8 providing volumetric datasets that can be retrospectively reformatted for viewing in arbitrary orientations, and used for imaging multiple intracranial lesions simultaneously. Our purpose was to assess the practical value of 3D HRMR VWI with SPACE sequence in resolving vessel segments suspicious for VBDAs.
Patient selection
All the patients were consecutively enrolled from August 2013 to January 2016 to undergo catheter angiography and 3D HRMR VWI (pre- and post-contrast), when they fulfilled the following criteria: 1) clinical symptoms and findings on computed tomographic angiography (CTA) or MRA suggestive of an intracranial VBDA; 2) no contraindication for MR imaging and catheter angiography. Demographics, clinical findings, imaging data, and risk factors such as hypertension, hyperlipidemia, diabetes mellitus, and cigarette smoking were also collected prospectively. Atherosclerotic intraplaque hemorrhage (IPH), atherosclerotic ulceration and aneurysm with wall atherosclerosis that might mimic dissection were excluded from this study. The stages were classified as early stage (less than 2 weeks, and 2 weeks to 2 months) and chronic stage (longer than 2 months) based on the time between symptom onset to VWI examination.
Catheter angiography protocol
All patients underwent catheter angiography on an Allura Xper FD20/10 (Philips Healthcare), Artis Zee Biplane, or Artis Zeego angiography unit (Siemens Healthcare). Catheter angiography on anteroposterior and lateral projections, and oblique projections as necessary were performed after placement of a diagnostic catheter in the V1 segment of the vertebral artery in question with injection of 5 ml of contrast (Iodixanol, GE healthcare) at a rate of 3ml per second at 300 Pa pressure. Then, 3D angiography was performed while injecting a total 18 ml contrast at a rate of 3ml per second at 300 Pa pressure.
Catheter angiography assessment
Direct and indirect signs of VBDAs were assessed by two experienced interventional neuroradiologists on both conventional and 3D catheter angiography images independently, blinded to the clinical and other imaging information including CTA, MRA and VWI. Analytical data was used to calculate intraobserver and interobserver’s agreement. The differences between two observers were solved by consensus. Direct signs included visualization of an intimal flap, or a double lumen. Indirect signs included long filiform or irregular stenosis, occlusion; or fusiform or serpentine aneurysmal dilation with focal, long filiform, or irregular stenosis (pearl-and-string sign); or fusiform or aneurysmal dilation at a non-branching site.2
MRI protocol
MR exam was performed with a 3T MRI scanner (Siemens, Magnetom Skyra, Erlangen, Germany) using a 20-channel phased-array head and neck joint coil. A 3D time-of-flight (TOF) MRA was first acquired to localize the intracranial arteries with the following parameters:TR/TE = 20/3.4 ms, FOV = 192 ×240 mm, thickness = 1 mm, matrix = 460×640, and NEX = 1, the voxel volume was 0.4 × 0.4 × 1 mm on MRA. HRMR VWI was acquired with a 3D SPACE T1W sequence in the coronal plane (45-mm-thick slab) to cover the major intracranial vessels as identified on the TOF MRA with the following parameters: TR/TE = 600/20 ms, FOV = 182 × 220 × 45 mm, matrix= 212 × 256 ×50, average = 1.5, echo train duration = 118, the voxel volume was 0.9 × 0.9 ×0.9 mm on SPACE T1W image. SPACE post-contrast T1WI was obtained 5 minutes after gadolinium injection (0.1 mmol/kg of gadopentetate dimeglumine, Magnevist; Bayer Schering Pharma, Berlin, Germany) with the same parameters as pre-contrast T1WI.
MRI reformation
Resource data of VWIs were reformatted to acquire long and short axial images of the vertebrobasilar artery, with voxel volume = 0.9 × 0.9 × 0.9 mm. Multiple lesions with varying locations and orientations were displayed with individually reconstructed projections (Figure 1-3).
MRI assessment
Direct and indirect signs of VBDAs were assessed by 2 neuroradiologists independently with at least 5 years of experience in reading intracranial HRMR VWI, and were blinded to the clinical and other imaging information including CTA, MRA and catheter angiography images. Analytical data was also used to calculate intraobserver and interobserver’s agreement. The differences between two observers were solved by consensus. The direct signs included intimal flap, double lumen and IMH. Intimal flap sign was defined as an abnormal linear structure separating a true lumen from a false lumen (Figure 1-3). To discriminate the intimal flap from the inflow artifact that can appear at the center of the lumen, we deemed only linear structures as an intimal flap when it extended to and from the arterial sidewall on SPACE pre- or post-contrast T1W images.2 Double lumen sign was defined as two lumens represented as two jets of flow void within one vessel on MRI. This is distinct from fenestration, which are separate vessels. IMH sign was defined as detection of eccentric or circumferential hyper-, iso-, or hypointense signal (corresponding to hemorrhage age) on pre-contrast T1WI within the arterial wall (Figure 2), 9 generally extending longitudinally and located in the proximal or distal segment of pseudolumen, or filled the pseudolumen entirely. Intramural, partially thrombosed haematoma (Mizutani type 3 dissection) was diagnosed on imaging when heterogenous, multi-aged hemorrhage in the vessel wall was identified11,12, which is classified into IMH.
IMH was differentiated from intraluminal thrombus by location and enhancement: IMH is separated from the lumen by the intimal flap with no or sometimes heterogeneous enhancement. Lesions were considered intraluminal thrombus when it was seen in a juxtaluminal location with obvious enhancement.10 Atherosclerotic IPH and ulceration which may mimic dissection was discriminated from IMH and excluded from this study with the following criteria: IPH and ulceration was still located within the atherosclerotic plaque with relatively small size, generally not associated with a focal enlargement of external diameter.3 Atherosclerosis within an aneurysmal wall which may mimic chronic IMH was determined and excluded with the following characteristics including: at sites of arterial bifurcation, not associated with intimal flap and double lumen, not associated with heterogeneous T1 hyperintense signal (recurrent hemorrhage).
The indirect signs were also assessed based on the luminal characteristics of VWI, similar to that of catheter angiography.
Lesion diagnosis
After assessment on catheter angiography and VWI, segments suspicious for VBDAs were given a final imaging diagnosis, individually. Based on catheter angiography, lesion was diagnosed as definite VBDAs by interventional neuroradiologists when intimal flap or double lumen was detected. On VWI, when IMH, intimal flap, or double lumen was found, it was considered a definite VBDA by neuroradiologists. If there were only indirect signs of dissection, the lesion was considered a possible VDBA. A lesion was considered segmental ectasia (Mizutani type 2), if there was only local dilation and normal wall thickness, without evidence of mural thrombosis.12
Statistical analysis
Continuous variables were described as mean ± standard deviation, or as interquartile range (if not normally distributed). Cohen’s k-statistic was computed to quantify the intra-observer and inter-oberver agreement for asessement of itimal flap, double lumen and IMH. A value of k > 0.75 was used to indicate a high level of agreement. After consensus, McNemar test was used to assess the difference for definitively diagnosing VBDAs and detecting direct dissection signs between VWI and catheter angiography. SPSS 11.5 (SPSS, Inc., Chicago, IL) was used for statistical analysis. All reported p values were 2-sided, and a p value of <0.05 was considered significant.
Patients
21 consecutive patients (Male: 14; female: 7) with 27 vessel segments suspicious for intracranial VBDAs were included in this single center study. The median age was 59.0 years (interquartile range: 49.0 to 62.5 years). Risk factors included hypertension (n=13, 61.9%), hyperlipidemia (n=5, 23.8%), diabetes mellitus (n=2, 9.5 %), and cigarette smoking (n=9, 42.9%). Of the 27 lesions, 8 lesions were located in the basilar artery, 16 lesions in the intracranial vertebral artery, and 3 lesions arising from the intracranial vertebral artery and extending into the basilar artery. Among the 21 patients, 3 patients presented with acute infarction in the territory of the parent artery, 17 with TIA, and 1 with subarachnoid hemorrhage (SAH). The mean interval between symptom onset and VWI examination was 30 days (interquartile range: 23 to 75.5 days). The patients were classified into early stage in 14 patients with 17 lesions (less than 2 weeks in 4 patients with 5 lesions, 2 weeks to 2 months in 10 patients with 12 lesions), and chronic stage (longer than 2 months) in 7 patients with 10 lesions. Catheter angiography was performed before VWI in 4 patients, after VWI in 16 patients, and on the same day with VWI in 1 patient. The median time between catheter angiography and MRI performance was 5 days (interquartile range: 1.5 to 7.5 days).
Intraobserver and interobserver agreement
On catheter angiography, the intraobserver agreement was high for detecting an intimal flap (k = 0.899) and double lumen (k = 0.899). The interobserver agreement was aslso high for detecting an intimal flap (k = 0.807) and double lumen (k = 0.807).
On VWI, the intraobserver agreement was high for detecting intimal flap (k = 0.899), double lumen (k = 0.833) and IMH (k = 0.852). The interobserver agreement was also high for detecting intimal flap (k = 0.886), double lumen (k = 0.824) and IMH (k = 0.777)
Final diagnosis
Catheter angiography and VWI data were available in all of the 27 vascular segments in question. Based on catheter angiography, 7 lesions in 7 patients were diagnosed as definite VBDAs with direct visualization of both an intimal flap and double lumen sign. There were 20 lesions in 14 patients that were deemed possible VBDAs with only indirect signs of dissection (Table 1, 2).
In contrast, based on VWI, all of the 27 lesions in the 21 patients were given a definite diagnosis, including 25 definite VBDAs in 19 patients, and 2 segmental ectasia in 2 patients (Figure 2). Thus, in this series, definitive diagnosis of a VDBA was more frequently made using VWI in comparison to catheter angiography (92.6%, 25/27 vs 25.9%, 7/27; p=0.000) (Table 1, 2). The definite diagnosis of segmental ectasia was only made by VWI,compared with catheter angiography (7.4%, 2/27 vs 0, 0/27). Furthermore, on the post-contrast VWI, all VBDAs showed extensive and dense wall enhancement. In contrast, segmental ectasias did not show obvious vessel wall enhancement.
Direct signs of dissection
In this series of possible VBDAs, intimal flap sign was more frequently detected on VWI than on catheter angiography (77.8%, 21/27 vs 25.9%, 7/27; p = 0.001) (Figure 1,3). Detection rate of double lumen sign was also higher on VWI (66.7%, 18/27 vs 25.9%, 7/27; p = 0.003) (Figure 1-3). Furthermore, IMH sign was detected on VWI in 51.9% (14/27) of lesions, which is not detectable on catheter angiography (0/27). Of 14 lesions with IMH, 5 concomitantly had a partially thrombosed haematoma (Mizutani type 3 dissection, Figure 2).
Comparison between early stage and chronic stage
On the VWI, there was no significant difference for the intimal flap sign, (76.5%, 13/17 vs 80.0%, 8/10; p = 1.000), double lumen sign (64.7%, 11/17 vs 70.0%, 7/10; p = 1.000), and the IMH (47.1%, 8/17 vs 60.0%, 6/10; p = 0.802) between the lesions in the early stage and chronic stage.
On the catheter angiography, there was also no significant difference for the intimal flap sign, (23.5%, 4/17 vs 30.0%, 3/10; p = 1.000), and double lumen sign (23.5%, 4/17 vs 30.0%, 3/10; p = 1.000) between the lesions in the early stage and chronic stage.
Indirect signs of dissection
Based on the luminal imaging, there was no difference in the indirect signs of dissection between catheter angiography and HRMR VWI (p = 0.406). However, the HRMR VWI provided more detailed information including actual affected vessel length and dilated vessel surface appearance in all the 27 lesions.
Our study showed that HRMR VWI was superior to catheter angiography in detecting dissecting signs and achieving definite diagnosis of VBDA, and allowed a promising way to accurately discriminate between VBDA and segmental ectasia as well, by assessing vessel wall morphological and signal patterns in these various disease states.
Based on the pathological findings, Mizutani et al classified nonatherosclerotic fusiform and dissecting aneurysms as type 1, classic dissecting aneurysm; type 2, segmental ectasia; type 3, dolichoectatic dissecting aneurysm; and type 4, saccular aneurysm at a non-branching site.12 A better understanding of the pathological features of each lesion may help to establish individual treatment strategies, considering the strong relationship between the pathological patterns and their clinical courses.12 Nowadays, given the difficulty in obtaining histopathological examination during clinical work, the superiority of HRMR VWI over catheter angiography for detecting pathognomonic radiological findings can help to differentiate between different types effectively.
An intimal flap has been regarded as the most reliable imaging finding for vascular dissection.3 However, this can be a subtle sign, and only observed in a minority of cases with catheter angiography.2 Our study showed that HRMR VWI with 3D SPACE sequence could detect intimal flaps in 21 of 27 lesions suspicious for VBDAs (77.8%), outperforming DSA, similar to results described in previous studies.3,8 For the other 4 VBDAs without detectable intimal flap on VWI, one reason may be due to healing of the dissection after the acute stage,1 resulting in intimal flap adherence to the parent vessel wall. A double lumen sign is also considered a reliable sign of vascular dissection. Detection of this sign relies on the identification of blood products in the pseudolumen13,14. An entry-exit type dissection occasionally has a constant flow of blood through the pseudolumen, resulting in signal flow-void similar to the true lumen on MRI13. On the contrast, an entry-only type dissection often has an intramural haemotoma in the pseudolumen,13 leading to various signal intensities according to hemorrhagic age on MRI.9
3D T1W images with high spatial resolution and black-blood effect is regarded as the optimum imaging method for detection of IMH.3 The positive rate of IMH was 51.9% (14/27) in our patients. Intramural hematoma in VBDA was best detected during the subacute or early chronic stage; but after 2 months, IMHs are isointense and can become difficult to recognize on MR images at this age.9 In some cases, IMH may be a recurrent process with both older and more acute blood products,11,12 leading to the heterogenous, partially thrombosed haematoma, which can be found in fatal chronic dissecting aneurysm (Mizutani type 3)11,12. This lesion is different from classic dissecting aneurysms (Mizutani type 1) regarding of the progress and outcomes, involving different therapeutic approach.14 VWI could be valuable for discrimination between type 1 and 3 dissecting aneurysms, and directing therapeutic management.
Previous study15 showed dissecting signs including intimal flap, double lumen sign, and IMH decreased significantly from the early stage to the chronic stage, which was different with our result. Some possible reasons could explain this. First, clinical symptoms in this study were not specific, and many patients showed recurrent TIA. Second, 5 patients had 2 or more dissecting aneurysms, and each aneurysm might happen in different stage in the same patient. Those reasons might confuse the result of the relationship between the stage and the image findings.
In this study, 2 cases with local dilation had wall thickness similar to the adjacent “normal” artery and without mural thrombosis were diagnosed as segmental ectasias (Mizutani type 2). The natural history of this entity is still not well understood and somewhat controversial.12,16 Vessel wall enhancement on post-contrast VWI was widely detected on VBDAs, but not on segmental ectasias. Increased gadolinium enhancement might have important value for distinguishing definite dissections from possible ones. A larger sample and follow-up with VWI is required to assess the diagnostic value of vessel wall enhancement.
3D HRMR VWI with SPACE sequence produce excellent black-blood effects, and depict the structure of vessel wall clearly, and can cover a large volume of intracranial arteries as well as providing isotropic, reconstructed images.7,8 Multiple lesions with varying locations and orientations can be captured in one scan and reconstructed views can be obtained readily - which is difficult for the 2D VWI technique.
There are several limitations in our study. First, this study only included patients with suspicious of dissection on clinical symptoms and CTA or MRA, which may limit the generalizability of the results. Second, some new technique such as DANTE could help improve blood suppression was not used in this study.17 Residual flow artifacts might affect the assessment of intimal flap. Third, resolution (0.9mm) may not be adequate for full assessment of VBDAs. Lastly and most importantly, the diagnoses could not be confirmed by histology, as all of the patients included in this study remain alive. Additionally, as the institution admits patients from a very large geographic area, many patients do not return for follow-up imaging or clinical evaluation limiting longitudinal analysis.
3D HRMR VWI could detect direct dissection signs more frequently than catheter angiography. This may help obtain definite diagnosis of intracranial VBDAs, and allow accurate differentiation between dissecting aneurysm and segmental ectasia as well. Further prospective study with larger sample was required to investigate the superiority of HRMR VWI for definite diagnosis of intracranial VBDAs than catheter angiography
IMH: intramural haematomas; VBDAs: vertebrobasilar dissecting aneurysms; 3D HRMR VWI: three-dimensional high-resolution magnetic resonance vessel wall imaging; 2D FSE: two dimensional fast spin echo; SPACE: Sampling Perfection with Application optimized contrasts by using different flip angle Evolutions; CTA: computed tomographic angiography; IPH: Atherosclerotic intraplaque hemorrhage; TOF: time-of-flight; SAH: subarachnoid hemorrhage
Ethics approval and consent to participate
This study was approved by the institutional ethics committee at the PLA Rocket Force General Hospital. Written informed consent was obtained from all patients for their participation in this study.
Consent to publish
Not applicable.
Availability of data and materials
The datasets used and analysed during the current study are available from the corresponding author on reasonable request.
Competing interests
The authors declare that they have no competing interests.
Funding
This work was supported by Beijing Municipal Science & Technology Commission (No: Z171100001017197), the National Key Research and Development Program of China (No: 2016YFC0103003), the National Basic Research Program (program 973) of China (2013CB733805) and the National Natural Science Foundation of China (81070925, 81471767). The funding body had no role or interference in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Authors’ contributions
XJZ, HCQ and W-JJ conceived and designed the research. FKH, YQZ, Y-EL, and FYM acquired the data, analyzed and interpreted the data. XJZ draft the manuscript. XJZ and W-JJ made critical revisions of the manuscript. All authors approved the final manuscript.
Acknowledgements
Not applicable.
Table 1. Comparison of catheter angiography and VWI for detecting dissecting signs and diagnosis
|
Catheter angiography |
VWI |
P |
Dissecting signs |
|
|
|
Intimal flap, n (%) |
7 (25.9%) |
21 (77.8%) |
0.001 |
Double lumen, n (%) |
7 (25.9%) |
18 (66.7%) |
0.003 |
IMH, n (%) |
- |
14 (51.9%) |
|
Diagnosis |
|
|
|
Definitive VBDA, n (%) |
7 (25.9%) |
25 (92.6%) |
0.000 |
Possible VBDA, n (%) |
20 (74.1%) |
0 |
|
Segmental ectasia, n (%) |
0 |
2 |
|
VWI, vessel wall images; IMH, intramural haematoma; VBDA, vertebrobasilar dissecting aneurysm
Table 2. Dissecting signs on catheter angiography, and VWI for the individual patient and lesion
Patient No. |
Symptoms and time from onset to imaging |
Lesion location |
Catheter angiography |
|
VWI |
||||
Direct sign |
Indirect sign |
Diagnosis |
Direct sign |
Indirect sign |
Diagnosis |
||||
1 |
Diplopia,90 days |
BA |
— |
Fusiform dilation |
Possible VBDA |
|
IMH |
Fusiform dilation |
VBDA |
2 |
Dizziness and limb weakness, 10 days |
Left ICVA |
— |
Fusiform dilation with stenosis |
Possible VBDA |
|
Intimal flap/ double lumen/ IMH |
Fusiform dilation with stenosis |
VBDA |
Right ICVA |
— |
Aneurysmal dilation |
Possible VBDA |
|
Intimal flap/ double lumen |
Aneurysmal dilation |
VBDA |
||
3 |
Recurrent vertigo, 61 days |
Left ICVA to BA |
Intimal flap/ double lumen |
Fusiform dilation with stenosis |
VBDA |
|
Intimal flap/ double lumen |
Fusiform dilation with stenosis |
VBDA |
4 |
Limb numbness and weakness, 30 days |
Right ICVA to BA |
— |
Fusiform dilation with stenosis |
Possible VBDA |
|
Intimal flap/ IMH |
Fusiform dilation with stenosis |
VBDA |
5 |
Slurred speech, 26 days |
Left ICVA to BA |
— |
Irregularity |
Possible VBDA |
|
Intimal flap/ double lumen |
Irregularity |
VBDA |
6 |
Recurrent dizziness,1460 days |
Left ICVA |
— |
Aneurysmal dilation |
Possible VBDA |
|
Intimal flap/ double lumen/ IMH |
Aneurysmal dilation |
VBDA |
7 |
Recurrent dizziness, 61 days |
Left ICVA |
— |
Aneurysmal dilation with stenosis |
Possible VBDA |
|
Intimal flap/ double lumen/ IMH |
Fusiform dilation |
VBDA |
Right ICVA |
— |
Irregularity |
Possible VBDA |
|
Intimal flap/ double lumen |
Irregularity |
VBDA |
||
8 |
Recurrent vertigo, 30 days |
BA |
— |
Stenosis |
Possible VBDA |
|
Intimal flap/ double lumen |
Fusiform dilation |
VBDA |
Left ICVA |
Intimal flap/ double lumen |
Aneurysmal dilation with stenosis |
VBDA |
|
IMH |
Fusiform dilation with stenosis |
VBDA |
||
9 |
Recurrent headache, 365 days |
Left ICVA |
— |
Aneurysmal dilation |
Possible VBDA |
|
Intimal flap/ double lumen/ IMH |
Aneurysmal dilation |
VBDA |
10 |
Recurrent headache,30 days |
Left ICVA |
— |
Aneurysmal dilation |
Possible VBDA |
|
IMH |
Aneurysmal dilation |
VBDA |
11 |
Recurrent dizziness,60 days |
BA |
Intimal flap/ double lumen |
Fusiform dilation with stenosis |
VBDA |
|
Intimal flap/ double lumen |
Fusiform dilation with stenosis |
VBDA |
12 |
Recurrent vertigo, 7 days |
Left ICVA |
— |
Fusiform dilation with stenosis |
Possible VBDA |
|
Intimal flap/ double lumen/ IMH |
Fusiform dilation with stenosis |
VBDA |
13 |
Coma, 4 hours |
Left ICVA |
— |
Aneurysmal dilation |
Possible VBDA |
|
Intimal flap/ double lumen |
Aneurysmal dilation |
VBDA |
14 |
Dizziness and slurred vision, 30 days |
BA |
Intimal flap/ double lumen |
Stenosis |
VBDA |
|
Intimal flap/ double lumen |
Irregularity |
VBDA |
Left ICVA |
— |
Stenosis |
Possible VBDA |
|
Intimal flap/ double lumen/ IMH |
Stenosis |
VBDA |
||
15 |
Recurrent headache, 1460 days |
BA |
— |
Irregularity |
Possible VBDA |
|
Intimal flap/ IMH |
Irregularity |
VBDA |
16 |
Dizziness, 1 day |
Right ICVA |
— |
Aneurysmal dilation |
Possible VBDA |
|
Intimal flap/ IMH |
Aneurysmal dilation |
VBDA |
17 |
Recurrent dizziness, 30 days |
BA |
Intimal flap/ double lumen |
Aneurysmal dilation with stenosis |
VBDA |
|
Intimal flap/ double lumen/ IMH |
Fusiform dilation with stenosis |
VBDA |
18 |
Dizziness, 60 days |
BA |
— |
Fusiform dilation |
Possible VBDA |
|
Intimal flap/ double lumen |
Fusiform dilation |
VBDA |
19 |
Recurrent headache, 365 days |
Distal segment of right ICVA |
Intimal flap/ double lumen |
Fusiform dilation |
VBDA |
|
Intimal flap/ double lumen |
Fusiform dilation |
VBDA |
Proximal segment of right ICVA |
Intimal flap/ double lumen |
Aneurysmal dilation |
VBDA |
|
Intimal flap/ double lumen |
Aneurysmal dilation |
VBDA |
||
|
Left ICVA |
— |
Occlusion |
Possible VBDA |
|
IMH |
Occlusion |
VBDA |
|
20 |
Limb numbness and weakness, 60 days |
BA |
— |
Fusiform dilation |
Possible VBDA |
|
— (Normal wall thickness) |
Fusiform dilation |
Segmental ectasia |
21 |
Dysphagia and right side weakness, 20 days |
Right ICVA |
— |
Fusiform dilation |
Possible VBDA |
|
— (Normal wall thickness) |
Fusiform dilation |
Segmental ectasia |
VWI, vessel wall images; BA, basilar artery; IMH, intramural haematoma; VBDA, vertebrobasilar dissecting aneurysm; ICVA, intracranial vertebral artery